• 1. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 2. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 3. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 4. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 5. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Hydroquinolones
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Quinolones and derivatives Hydroquinolones

Introduction to 6-Ethoxyquinolin-4-ol (CAS No. 303121-11-1)

6-Ethoxyquinolin-4-ol, identified by its Chemical Abstracts Service (CAS) number 303121-11-1, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology. This compound belongs to the quinoline family, a class of molecules known for their diverse biological activities and applications in drug development. The presence of an ethoxy group at the 6-position and a hydroxyl group at the 4-position introduces unique electronic and steric properties, making it a promising candidate for further exploration in synthetic chemistry and bioactivity studies.

The structural framework of 6-Ethoxyquinolin-4-ol combines the aromatic stability of the quinoline core with functional groups that can participate in various chemical reactions, including hydrogen bonding, π-stacking interactions, and metal coordination. These features have positioned it as a versatile scaffold for designing novel therapeutic agents. Recent advancements in computational chemistry and molecular modeling have enabled researchers to predict the potential binding modes of this compound with biological targets, such as enzymes and receptors, thereby facilitating rational drug design.

In the realm of medicinal chemistry, 6-Ethoxyquinolin-4-ol has been investigated for its potential pharmacological properties. Studies have suggested that derivatives of quinoline, including this compound, may exhibit antimicrobial, anti-inflammatory, and anticancer effects. The ethoxy substituent at the 6-position is particularly noteworthy, as it can modulate the electronic properties of the quinoline ring, influencing its interaction with biological targets. Additionally, the hydroxyl group at the 4-position provides a site for further functionalization, allowing for the development of more complex derivatives with enhanced bioactivity.

One of the most exciting areas of research involving 6-Ethoxyquinolin-4-ol is its application in anticancer therapy. Quinoline derivatives have shown promise in targeting various cancer pathways, including those involved in cell proliferation and apoptosis. Preliminary studies have indicated that 6-Ethoxyquinolin-4-ol may inhibit the activity of kinases and other enzymes critical for tumor growth. Furthermore, its ability to cross the blood-brain barrier makes it an attractive candidate for treating central nervous system (CNS) tumors. The integration of 6-Ethoxyquinolin-4-ol into combination therapies could potentially overcome resistance mechanisms observed in conventional cancer treatments.

The synthesis of 6-Ethoxyquinolin-4-ol presents an interesting challenge due to its complex structure. Traditional synthetic routes often involve multi-step processes that require careful optimization to achieve high yields and purity. Modern synthetic methodologies, such as transition-metal-catalyzed cross-coupling reactions and asymmetric synthesis, have opened new avenues for constructing this compound more efficiently. These advances not only improve scalability but also enable access to a broader range of derivatives for structural-activity relationship (SAR) studies.

From a biochemical perspective, 6-Ethoxyquinolin-4-ol has been studied for its interaction with metal ions, which play crucial roles in many biological processes. The hydroxyl group at the 4-position can coordinate with metals such as copper and iron, suggesting potential applications in metallodrug development. Such interactions could be exploited to design compounds that target metal-dependent enzymes or pathways involved in diseases like neurodegeneration and inflammation.

The pharmacokinetic properties of 6-Ethoxyquinolin-4-ol are also under investigation to ensure its suitability for clinical applications. Factors such as solubility, stability, and metabolic clearance are critical determinants of a drug's efficacy and safety profile. Computational tools have been employed to predict these properties early in the drug discovery process, reducing the time and cost associated with experimental testing.

In conclusion,6-Ethoxyquinolin-4-ol (CAS No. 303121-11-1) represents a fascinating molecule with significant potential in pharmaceutical research. Its unique structural features make it a valuable scaffold for developing novel therapeutic agents targeting various diseases. As research continues to uncover new biological activities and synthetic strategies,6-Ethoxyquinolin-4-ol is poised to play an important role in advancing our understanding of drug design and development.

• 13720-91-7(4-Ethoxyquinoline)
• 166589-60-2(2-Ethoxy-9H-carbazole)
• 161327-44-2(4,8-diethoxyquinoline)
• 37865-86-4(6-Ethoxy-1H-indole)
• 22883-85-8(6-ethoxyquinoline)
• 198704-91-5(Quinoline, 6-ethoxy-, hydrochloride (1:1))
• 1051315-78-6(2-(7-Methoxyquinolin-4-yloxy)ethanol)
• 859831-51-9(4-ethoxy-9H-Carbazole)
• 1208935-09-4(2-((1H-Indol-4-yl)oxy)ethanol)
• 23456-82-8(4-ethoxy-1H-indole)